Crescendo Biologics
UKEntry
2018
Hold
8yr
Status
Active
Who owns Crescendo Biologics?
Crescendo Biologics is currently owned by Sofinnova Partners through Sofinnova Capital IX (2018 vintage), since 2018. Across its history, Crescendo Biologics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Capital IX · 2018 · Life Sciences VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2018 · present
Andera PartnersActive
2018 · present(8yr) · BioDiscovery 5 · 2017 · VC
Sofinnova PartnersActive
2018 · present(8yr) · Sofinnova Capital IX · 2018 · Life Sciences VC
Future Planet CapitalActive
present · UK Innovation and Science Seed Fund · 2012 · VC
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
Switzerland
US
Italy
More PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceTrack Crescendo Biologics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Crescendo Biologics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue